Fruscio, Robert

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study

Van Calster, B., Van Hoorde, K., Valentin, L., Testa, A. C., Fischerova, D., Van Holsbeke, C., Savelli, L., Franchi, D., Epstein, E., Kaijser, J., et al. (2014) · BMJ

Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancer

Cited by 510

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition

Parikh, A., Lee, C., Joseph, P., Marchini, S., Baccarini, A., Kolev, V., Romualdi, C., Fruscio, R., Shah, H., Wang, F., et al. (2014) · Nature Communications

MicroRNA in disease regulationTGF-β signaling in diseases

Cited by 258

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer

Marchini, S., Fruscio, R., Clivio, L., Beltrame, L., Porcu, L., Nerini, I. F., Cavalieri, D., Chiorino, G., Cattoretti, G., Mangioni, C., et al. (2013) · European Journal of Cancer

Ovarian cancer diagnosis and treatmentCancer Cells and Metastasis

Cited by 176

External Validation of Diagnostic Models to Estimate the Risk of Malignancy in Adnexal Masses

Van Holsbeke, C., Van Calster, B., Bourne, T., Ajossa, S., Testa, A. C., Guerriero, S., Fruscio, R., Lissoni, A. A., Czekierdowski, A., Savelli, L., et al. (2012) · Clinical Cancer Research

Ovarian cancer diagnosis and treatmentAI in cancer detection

Cited by 87

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations

Lubinski, J., Kotsopoulos, J., Moller, P., Pal, T., Eisen, A., Peck, L., Karlan, B. Y., Aeilts, A., Eng, C., Bordeleau, L., et al. (2024) · JAMA Oncology

BRCA gene mutations in cancerMRI in cancer diagnosis

Cited by 82

Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations

Kotsopoulos, J., Gronwald, J., Huzarski, T., Møller, P., Pal, T., McCuaig, J. M., Singer, C. F., Karlan, B. Y., Aeilts, A., Eng, C., et al. (2024) · JAMA Oncology

BRCA gene mutations in cancerMultiple and Secondary Primary Cancers

Cited by 56

Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis

Metcalfe, K., Huzarski, T., Gronwald, J., Kotsopoulos, J., Kim, R., Moller, P., Pal, T., Aeilts, A., Eisen, A., Karlan, B., et al. (2024) · British Journal of Cancer

BRCA gene mutations in cancerGlobal Cancer Incidence and Screening

Cited by 46

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

Kotsopoulos, J., Gronwald, J., Huzarski, T., Aeilts, A., Randall Armel, S., Karlan, B., Singer, C. F., Eisen, A., Tung, N., Olopade, O., et al. (2023) · Breast Cancer Research and Treatment

BRCA gene mutations in cancerCancer Risks and Factors

Cited by 26

Histologic and metabolic assessment in a cohort of patients with genital prolapse: preoperative stage and recurrence investigations

Manodoro, S., Spelzini, F., Cesana, M. C., Frigerio, M., Maggioni, D., Ceresa, C., Penati, C., Sicuri, M., Fruscio, R., Nicolini, G., et al. (2017) · Minerva Obstetrics and Gynecology

Pelvic floor disorders treatmentsUterine Myomas and Treatments

Cited by 26

Ultrasound‐based risk model for preoperative prediction of lymph‐node metastases in women with endometrial cancer: model‐development study

Eriksson, L. S. E., Epstein, E., Testa, A. C., Fischerova, D., Valentin, L., Sladkevicius, P., Franchi, D., Frühauf, F., Fruscio, R., Haak, L. A., et al. (2020) · Ultrasound in Obstetrics & Gynecology

Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatment

Cited by 24